Evidence map›Paper›PMID 30616564›Full record

ArticleBMC infectious diseases2019

Diversity of upper respiratory tract infections and prevalence of Streptococcus pneumoniae colonization among patients with fever and flu-like symptoms.

Jialiang Tang, Jinkun Chen, Tingting He, Zhuojing Jiang, Jiale Zhou, Bin Hu, Shangxin Yang

Abstract read
In one paragraph

Article in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Vaccines for the common cold.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. Article
  3. Carmofur Exhibits Antimicrobial Activity AgainstAntibiotics (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. SerumPeerJ · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jialiang TangShaoxing Center for Disease Control and Prevention, Shaoxing, Zhejiang, China.
Jinkun ChenShaoxing Center for Disease Control and Prevention, Shaoxing, Zhejiang, China.
Tingting HeShaoxing Center for Disease Control and Prevention, Shaoxing, Zhejiang, China.
Zhuojing JiangShaoxing Center for Disease Control and Prevention, Shaoxing, Zhejiang, China.
Jiale ZhouIngeniGen XunMinKang Biotechnology Inc. Shaoxing, Zhejiang, China.
Bin HuIngeniGen XunMinKang Biotechnology Inc. Shaoxing, Zhejiang, China.
Shangxin YangZhejiang-Californina International Nanosystems Institute, Zhejiang University, Zhejiang, Hangzhou, China. shangxinyang@mednet.ucla.edu.ORCID http://orcid.org/0000-0001-9991-1178

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany upper respiratory pathogens cause similar symptoms. In China, routine molecular tests for upper respiratory pathogens are not widely performed and antibiotics abuse in treating upper respiratory tract infections (URTIs) is a major public health concern.

methodsWe performed qualitative real-time PCR tests to detect common upper respiratory tract pathogens including 9 viruses and 3 bacteria in 1221 nasopharyngeal swabs from patients with fever and influenza-like symptoms in a Chinese city. A quantitative real-time PCR was also performed to measure the bacterial density of the colonizing Streptococcus pneumoniae in these samples.

resultsWe found very diverse pathogens including 81.7% viruses, 11.6% bacteria and 6.7% mixed viruses and bacteria. S. pneumoniae colonization was found in 8.0% of the cases but most of them had low bacterial density (Mean = 3.9 log cfu/ml). We also discovered an increase of S. pneumoniae colonization frequency (but not the density) in patients with detectable upper respiratory tract pathogens, in a pathogen variety-dependent manner.

conclusionsOur study provided strong evidence against empiric antibiotic use for treating URTIs, and highlighted a strong need for improving the diagnostic capacity for URTIs by using more molecular testing in China.

Indexed as

AdolescentAdultAgedAged, 80 and overChildChild, PreschoolChinaFeverHumansInfantInfluenza, HumanMiddle AgedPneumococcal InfectionsPrevalenceRespiratory Tract InfectionsStreptococcus pneumoniaeFlu-like symptomsMolecular testingRespiratory pathogensStreptococcus pneumoniae colonizationUpper respiratory tract infections

Identifiers

PMID30616564
PMCPMC6323860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.